WALTHAM, Mass.--(BUSINESS WIRE)--Korsana Biosciences, Inc. (“Korsana” or the “Company”), a biotechnology company discovering and developing novel therapies to reduce the burden of neurodegenerative diseases, today announced that Jonathan Violin, Ph.D., President and Chief Executive Officer, will present at the Stifel 2026 Virtual CNS Forum on Tuesday, March 17, 2026 at 3:00 pm ET. A live webcast of the company presentation will be available on the Company's website at www.korsana.com. A replay.